Gateway Health Alliance   Report issue

For profit Phase 2
Founded: Danville VA United States (1994)
Status: No NME R&D (1994)

Organization Overview

First Clinical Trial
2006
NCT00645775
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2012

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 2 Trials (1)

resveratrol (1 trial)

Drugs in Other Trials (3)

cissus (1 trial)

irvingia (1 trial)

irvingia gabonensis (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Cardiovascular Diseases (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 3
  • # of Trial APIs: 4